Topics
Pediatric-type diffuse low-grade gliomas | Treatment | Targeted therapy | Trametinib
Home > Publications > Topics > Pediatric-type diffuse low-grade gliomas > Treatment > Targeted therapy > Trametinib
Castellano-Damaso
S, Vazquez-Gomez F, Moreno-Carrasco JL, Arce B, Borrego P,
Lassaletta A.
Continuous response
despite reduced dose of trametinib as single agent in an
adolescent with a relapsed disseminated pediatric low-grade glioma
KIAA1549-BRAF
fusion positive: a case report and review of the literature.
Front
Oncol. 2024 May 23;14:1381354. doi:
10.3389/fonc.2024.1381354. PMID:
38846974. Case report; Review. ˍ